Economic conditions, interest rate and currency exchange rate fluctuations, technological advances and patents attained by competitors; challenges in new product development, including obtaining regulatory approvals;.. To read complete for more information and the results of clinical studies, visit Phosphagenics ‘ site pleaseSafe Harbor StatementThis press release contains forward-looking statements based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results may vary materially from the expectations and projections Phosphagenics risks and uncertainties include general industry conditions and competition;.
A transdermal pain product with oxycodone Dr. Esra Ogru, Executive Vice President of Research and Development at Phosphagenics, said: Our goal is a large unmet need by our technology to oxycodone in a sustained – release address treat formulation to pain over a period of 24 hours. .. Be conductedenics conduct a Phase 1 Transdermal Oxycodone Clinical examinationPhosphagenics Limited announced that after the successful preclinical studies, it is a phase 1 transdermal oxycodone should serve clinical study to will commit chronic pain patients with a sustained-release pain management product.Especially , the legislation that any decisions that all decisions be held out of respect, and in consideration of, of dignity and uniqueness of personal patients. – ‘These sufferers and their families be losing in the gaps applicable law, too many times on terribly, unnecessary suffering on the side of which patient and the patient ones,’said Chairman Daniel Sisto Hanys. ‘We must free them from this to the patient the patient every opportunity has fulfilled his or her own desires. It an essential right for all we. ‘.. The legislation, aka to the ‘Family Health Care choices Act’allows medical care decision privately held the patient’s family or friends on the basis of common sense :: which patient’s expressed wishes of or, if known, ill the best interests.